SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma

Pierce K. H. Chow(National Cancer Centre Singapore), Ho‐Seong Han(Seoul National University Bundang Hospital), Chien‐Fu Hung(Johns Hopkins University), Ganesh Lekurwale(SingHealth), Laurentius A. Lesmana(University of Indonesia), Richard Lo(SingHealth), Su Pin Choo(National Cancer Centre Singapore), Val Gebski(The University of Sydney), Tjakra Wibawa Manuaba(SingHealth), Yun Hwan Kim(SingHealth), Kiang Hiong Tay(Singapore General Hospital), Peng Chung Cheow(Singapore General Hospital), Hyun‐Ki Yoon(SingHealth), Si Hyun Bae(University of California, Los Angeles), Kenneth Yuh Yen Kok(Universiti Brunei Darussalam), Chiong Soon Law(SingHealth), Aloysius Raj(SingHealth), Wei Ming Liew(SingHealth), Brian K. P. Goh(Singapore General Hospital), Po‐Chin Liang(National Taiwan University Hospital), Khee Chee Soo(National Cancer Centre Singapore), Ian H.Y.(SingHealth), Adam Bartlett(SingHealth), Ariunaa Khasbazar(SingHealth), Cheng‐Yuan Peng(China Medical University), Chanisa Chotipanich(SingHealth), Choon Hua Thng(National Cancer Centre Singapore), Janus P. Ong(Cleveland Clinic), Catherine Teh(SingHealth), Rolley Rey Lobo(SingHealth), Yun Won Jong(SingHealth), Mihir Gandhi(Duke-NUS Medical School), Boon Koon Yoong(SingHealth), Rheun‐Chuan Lee(Taipei Veterans General Hospital), David Chee Eng Ng(SingHealth), Anthony Soon Whatt Goh(SingHealth), Albert Low(SingHealth), Kieron Lim(SingHealth), Kenneth Mak(Ministry of Health), Say‐Beng Tan(SingHealth)
Journal of Clinical Oncology
March 2, 2018
Cited by 653


Related Papers